Correlation Between Neurocrine Biosciences and Orexo AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Orexo AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Orexo AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Orexo AB, you can compare the effects of market volatilities on Neurocrine Biosciences and Orexo AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Orexo AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Orexo AB.

Diversification Opportunities for Neurocrine Biosciences and Orexo AB

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Neurocrine and Orexo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Orexo AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orexo AB and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Orexo AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orexo AB has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Orexo AB go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Orexo AB

If you would invest  108.00  in Orexo AB on December 30, 2024 and sell it today you would earn a total of  0.00  from holding Orexo AB or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Neurocrine Biosciences  vs.  Orexo AB

 Performance 
       Timeline  
Neurocrine Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Neurocrine Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Orexo AB 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Orexo AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Orexo AB is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Neurocrine Biosciences and Orexo AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurocrine Biosciences and Orexo AB

The main advantage of trading using opposite Neurocrine Biosciences and Orexo AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Orexo AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orexo AB will offset losses from the drop in Orexo AB's long position.
The idea behind Neurocrine Biosciences and Orexo AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio